3.9 Article

Development of antibodies to PspA families 1 and 2 in children after exposure to Streptococcus pneumoniae

期刊

CLINICAL AND VACCINE IMMUNOLOGY
卷 15, 期 10, 页码 1529-1535

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/CVI.00181-08

关键词

-

资金

  1. Merck Co. Inc.
  2. Sanofi Pasteur
  3. Wyeth Vaccines
  4. World Health Organization [V23/181/116]

向作者/读者索取更多资源

Pneumococcal surface protein A ( PspA) is an important virulence factor of Streptococcus pneumoniae. PspA exists as two major families, which include variable but serologically cross-reactive proteins. Previous studies with a family 1 PspA antigen suggested that children develop low concentrations of anti-PspA after pneumococcal carriage or infection. In this study, antibody to PspA families 1 and 2 was measured by an enzyme immunoassay of the serum and saliva of children with a history of culture-proven pneumococcal colonization and/or acute otitis media and in the serum and saliva of adults. The PspA families of the pneumococcal strains isolated from children were determined. The majority of the children had high serum and salivary anti-PspA concentrations to the PspA family they had encountered and low concentrations to the other, whereas adults had high antibody concentrations to both PspA families, both in serum and in saliva. The results suggest that children have a relatively family-specific antibody response to the PspA family they have been exposed to and that any PspA vaccine for children should contain members of both major PspA families.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.9
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据